Nikko Asset Management Americas Inc. Trims Position in Personalis, Inc. (NASDAQ:PSNL)

Nikko Asset Management Americas Inc. cut its position in Personalis, Inc. (NASDAQ:PSNL) by 7.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 733,313 shares of the company’s stock after selling 59,295 shares during the period. Nikko Asset Management Americas Inc.’s holdings in Personalis were worth $4,231,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. grew its stake in Personalis by 98.4% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 108,788 shares of the company’s stock valued at $585,000 after acquiring an additional 53,965 shares in the last quarter. Quantbot Technologies LP purchased a new position in Personalis during the third quarter valued at $210,000. Walleye Capital LLC purchased a new position in Personalis during the third quarter valued at $897,000. Centiva Capital LP purchased a new position in Personalis during the third quarter valued at $380,000. Finally, State Street Corp grew its stake in Personalis by 34.5% during the third quarter. State Street Corp now owns 175,142 shares of the company’s stock valued at $942,000 after acquiring an additional 44,900 shares in the last quarter. 61.91% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on PSNL. Needham & Company LLC cut their target price on shares of Personalis from $7.25 to $7.00 and set a “buy” rating for the company in a research note on Friday, February 28th. Lake Street Capital increased their price objective on shares of Personalis from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Wednesday, January 8th. Finally, HC Wainwright reiterated a “buy” rating and set a $8.00 price objective on shares of Personalis in a research report on Friday, February 28th.

Personalis Stock Up 1.7 %

PSNL stock opened at $3.63 on Monday. Personalis, Inc. has a 52 week low of $1.13 and a 52 week high of $7.20. The company has a fifty day simple moving average of $4.97 and a two-hundred day simple moving average of $4.91. The firm has a market capitalization of $320.39 million, a P/E ratio of -2.16 and a beta of 1.73.

Personalis (NASDAQ:PSNL) last released its quarterly earnings data on Thursday, February 27th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.09. The business had revenue of $16.80 million during the quarter, compared to analyst estimates of $15.48 million. Personalis had a negative net margin of 104.52% and a negative return on equity of 66.07%. As a group, analysts anticipate that Personalis, Inc. will post -1.4 EPS for the current year.

Personalis Company Profile

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.